Cardioneuroablation for Drug Refractory Vasovagal Syncope After COVID-19 Infection

Cardioneuroablation for Drug Refractory Vasovagal Syncope After COVID-19 Infection

Cardioneuroablation is a novel approach to treat patients with recurrent vasovagal syncope (VVS), targeting the ganglionated plexi around the atria and thus reducing the vagal input to the heart. This study reports a case of drug-refractory VVS after COVID-19 infection, successfully managed with car...

Full description

Bibliographic Details
Main Authors: Stefanos Zafeiropoulos, MD, PhD, Nicholas J. Beccarino, MD, Stavros Stavrakis, MD, PhD, Stavros Zanos, MD, PhD, Raman Mitra, MD, PhD
Format: Article
Language:English
Published: Elsevier 2024-07-01
Series:JACC: Case Reports
Subjects:
cardioinhibitory
cardioneuroablation
COVID-19
syncope
vasovagal
Online Access:http://www.sciencedirect.com/science/article/pii/S2666084924001669

Internet

http://www.sciencedirect.com/science/article/pii/S2666084924001669

Similar Items